Stratos Wealth Partners, Ltd. Regenxbio Inc. Transaction History

Stratos Wealth Partners, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$39.11 - $75.15 $8,799 - $16,908	-225 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$65.0 - $82.15 $14,625 - $18,483	225 New	225 $17,000
Q2 2018 Aug 13, 2018	SELL	$27.2 - $74.35 $6,120 - $16,728	-225 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$24.05 - $37.5 $5,411 - $8,437	225 New	225 $7,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.